Table 2.
Best response to BV, N=37 |
Response to combination chemotherapy (ICE/DICE/IGEV/GND) post-BV, N=18 |
Disease Status at AHCT, N=33 |
|
---|---|---|---|
ORR | 25/37 (68%) | 16/18 (89%) | |
CR | 13/37 (35%) | 11/18 (61%) | 24/33 (73%) |
PR | 12/37 (32%) | 5/18 (28%) | 9/33 (27%) |
SD | 10/37 (27%) | 1/18 (6%) | 1/33 (3%) |
PD | 2/37 (5%) | 1/18 (6%) |